Clinical Trials Logo

Clinical Trial Summary

This study will assess the efficacy of everolimus as an inhibitor of fibrosis progression in liver transplant patients who have a recurrence of hepatitis C viral infection in the transplant


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00582738
Study type Interventional
Source Novartis
Contact
Status Terminated
Phase Phase 2
Start date December 2007
Completion date January 2010